US 8039500
Fused heterocyclic compounds
granted A61PA61P25/00A61P25/22
Quick answer
US patent 8039500 (Fused heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P25/00, A61P25/22, A61P25/24, A61P35/00